Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Mentor Capital Invests USD1 Million in GW Pharma 12
Partnerships 13
GW Pharma Enters into Research Agreement with New South Wales 13
GW Pharma Enters Into Distribution Agreement With Ipsen For Sativex 14
Equity Offering 15
GW Pharma Raises USD317.4 Million in Public Offering of Shares 15
GW Pharma Raises USD290 Million in Public Offering of American Depositary Shares 17
GW Pharma Completes Exercise of Underwriter’s Over Allotment Option for Public Offering of ADSs for USD206 Million 19
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 21
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 23
GW Pharma Announces Partial Exercise Of Underwriter’s Option Of American Depository Shares For US$33 Million 25
Acquisition 27
GW Pharma May Sell Itself 27
GW Pharmaceuticals Plc – Key Competitors 28
GW Pharmaceuticals Plc – Key Employees 29
GW Pharmaceuticals Plc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 31
May 08, 2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results 33
Feb 05, 2018: GW Pharmaceuticals Reports Q1 Fiscal 2018 Financial Results 34
Dec 04, 2017: GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress 37
Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 39
May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 41
Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 43
Corporate Communications 44
Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 44
May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 45
Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director – UK 46
Legal and Regulatory 47
Aug 02, 2018: Certara Software or Services supported 95% of the US FDA novel drug approvals in first half of 2018 47
Government and Public Interest 48
Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mentor Capital Invests USD1 Million in GW Pharma 12
GW Pharma Enters into Research Agreement with New South Wales 13
GW Pharma Enters Into Distribution Agreement With Ipsen For Sativex 14
GW Pharma Raises USD317.4 Million in Public Offering of Shares 15
GW Pharma Raises USD290 Million in Public Offering of American Depositary Shares 17
GW Pharma Completes Exercise of Underwriter's Over Allotment Option for Public Offering of ADSs for USD206 Million 19
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 21
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 23
GW Pharma Announces Partial Exercise Of Underwriter’s Option Of American Depository Shares For US$33 Million 25
GW Pharma May Sell Itself 27
GW Pharmaceuticals Plc, Key Competitors 28
GW Pharmaceuticals Plc, Key Employees 29
GW Pharmaceuticals Plc, Other Locations 30
GW Pharmaceuticals Plc, Subsidiaries 30
List of Figures
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Devices Deals, 2012 to YTD 2018 10